{
  "pmid": "32758630",
  "uid": "32758630",
  "title": "Low prescription of tumor necrosis alpha inhibitors in hidradenitis suppurativa: A cross-sectional analysis.",
  "abstract": "",
  "authors": [
    {
      "last_name": "Orenstein",
      "fore_name": "Lauren A V",
      "initials": "LAV",
      "name": "Lauren A V Orenstein",
      "affiliations": [
        "Department of Dermatology, Emory University School of Medicine, Atlanta, Georgia."
      ]
    },
    {
      "last_name": "Wright",
      "fore_name": "Shari",
      "initials": "S",
      "name": "Shari Wright",
      "affiliations": [
        "Department of Dermatology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New Hyde Park, New York."
      ]
    },
    {
      "last_name": "Strunk",
      "fore_name": "Andrew",
      "initials": "A",
      "name": "Andrew Strunk",
      "affiliations": [
        "Department of Dermatology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New Hyde Park, New York."
      ]
    },
    {
      "last_name": "Garg",
      "fore_name": "Amit",
      "initials": "A",
      "name": "Amit Garg",
      "affiliations": [
        "Department of Dermatology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New Hyde Park, New York. Electronic address: amgarg@northwell.edu."
      ]
    }
  ],
  "journal": {
    "title": "Journal of the American Academy of Dermatology",
    "iso_abbreviation": "J Am Acad Dermatol",
    "issn": "1097-6787",
    "issn_type": "Electronic",
    "volume": "84",
    "issue": "5",
    "pub_year": "2021",
    "pub_month": "May"
  },
  "start_page": "1399",
  "end_page": "1401",
  "pages": "1399-1401",
  "language": "eng",
  "publication_types": [
    "Letter"
  ],
  "keywords": [
    "Adalimumab",
    "Adult",
    "Cross-Sectional Studies",
    "Dermatology",
    "Drug Prescriptions",
    "Female",
    "Hidradenitis Suppurativa",
    "Humans",
    "Infliximab",
    "Male",
    "Middle Aged",
    "Practice Patterns, Physicians'",
    "Tumor Necrosis Factor-alpha"
  ],
  "article_ids": {
    "pubmed": "32758630",
    "doi": "10.1016/j.jaad.2020.07.108",
    "pii": "S0190-9622(20)32310-0"
  },
  "doi": "10.1016/j.jaad.2020.07.108",
  "dates": {
    "completed": "2021-08-25",
    "revised": "2021-08-25"
  },
  "chemicals": [
    "TNF protein, human",
    "Tumor Necrosis Factor-alpha",
    "Infliximab",
    "Adalimumab"
  ],
  "grants": [],
  "search_metadata": {
    "search_type": "all_publications",
    "retrieved_date": "2025-07-30T14:22:09.300878",
    "pmid": "32758630"
  }
}